These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Hirano K; Takahashi M; Kazumi Y; Fukasawa Y; Abe C Tuber Lung Dis; 1997; 78(2):117-22. PubMed ID: 9692180 [TBL] [Abstract][Full Text] [Related]
8. Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of Sheik Amamuddy O; Musyoka TM; Boateng RA; Zabo S; Tastan Bishop Ö Comput Struct Biotechnol J; 2020; 18():1103-1120. PubMed ID: 32489525 [TBL] [Abstract][Full Text] [Related]
9. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Sun Z; Zhang Y Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264 [TBL] [Abstract][Full Text] [Related]
10. Pyrazinamide resistance of novel mutations in Ali A; Khan MT; Khan A; Ali S; Chinnasamy S; Akhtar K; Shafiq A; Wei DQ RSC Adv; 2020 Sep; 10(58):35565-35573. PubMed ID: 35515677 [TBL] [Abstract][Full Text] [Related]
11. Role of pncA gene mutations W68R and W68G in pyrazinamide resistance. Aggarwal M; Singh A; Grover S; Pandey B; Kumari A; Grover A J Cell Biochem; 2018 Mar; 119(3):2567-2578. PubMed ID: 28980723 [TBL] [Abstract][Full Text] [Related]
12. Mechanistic analysis of A46V, H57Y, and D129N in pyrazinamidase associated with pyrazinamide resistance. Khan MT; Chinnasamy S; Cui Z; Irfan M; Wei DQ Saudi J Biol Sci; 2020 Nov; 27(11):3150-3156. PubMed ID: 33100877 [TBL] [Abstract][Full Text] [Related]
13. Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N. Junaid M; Khan MT; Malik SI; Wei DQ J Chem Inf Model; 2019 Jan; 59(1):498-508. PubMed ID: 30481017 [TBL] [Abstract][Full Text] [Related]
14. Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Hameed HA; Tan Y; Islam MM; Lu Z; Chhotaray C; Wang S; Liu Z; Fang C; Tan S; Yew WW; Zhong N; Liu J; Zhang T Infect Drug Resist; 2020; 13():217-227. PubMed ID: 32158237 [TBL] [Abstract][Full Text] [Related]
15. Insights Into Mutations Induced Conformational Changes and Rearrangement of Fe Nangraj AS; Khan A; Umbreen S; Sahar S; Arshad M; Younas S; Ahmad S; Ali S; Ali SS; Ali L; Wei DQ Front Mol Biosci; 2021; 8():633365. PubMed ID: 34095218 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide]. Hong CY; Wang F; Gui J; Liu XL Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731 [TBL] [Abstract][Full Text] [Related]
17. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989 [TBL] [Abstract][Full Text] [Related]
18. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313 [TBL] [Abstract][Full Text] [Related]
19. Insights from the molecular mechanism of pyrazinamide to mutated pyrazinamidase linked to the Pitaloka DAE; Arfan A; Ramadhan DSF; Chaidir L J Biomol Struct Dyn; 2024; 42(2):759-765. PubMed ID: 37096659 [TBL] [Abstract][Full Text] [Related]
20. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping]. Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]